TABLE I
Stimulation ofMacrophage ADCC by rIFN--y, IL-2, IFN-a, and IFN-(3 RALPH ET AL .
BRIEF DEFINITIVE REPORT 713 Macrophages were tested 2 d with medium, Con A-induced lymphokine (LK), or factors, and then assayed for killing R 1 targets at an E/T ratio of 6. Targets were not affected by antiserum or LKs in the absence of macrophages . * Viable targets (X10'/ml) at 9 and 24 h.
ADCC induced by agent pretreatment was determined by comparison with media control. § Significantly different from medium control, p < 0.05.
Results
ADCC-stimulating Effect of Individual IFNs and IL-2 . We previously showed that a 2-d incubation of mouse peritoneal exudate macrophages in culture with Con A-induced lymphokine was optimal for stimulating ADCC (1). We followed this protocol to study the effect of individual factors. The R I thymoma cell line was used as the target since it is very sensitive to macrophage ADCC, but fairly resistant to nonspecific killing and NK lysis (3) . The assay used visual counting of target cells surviving macrophage coculture at 9 and 24 h. The R 1 targets are easily distinguished from peritoneal cells by size . A single batch of Con Ainduced lymphokine was used throughout these experiments, and it contained 35 U/ml of IFN activity, 92 U/ml IL-2, and 58 U/ml IL-4, and <0 .2 ng/ml LPS. Table I shows that recombinant murine IFN-y greatly potentiates ADCC at 5 and 50 U/ml, with moderate effects seen at 1 U/ml . Comparison of the titration of Con A-induced lymphokine and IFN-y in three experiments (Table  I and not shown) suggests that 5% lymphokine has the activity of^r2-4 U/ml IFN-y in this assay. Rat rIFN-y (Amgen, Thousand Oaks, CA) had almost the identical effect as mouse IFN-y on murine macrophage ADCC .
IFN-ca and IFN-,Q also stimulate ADCC, but at higher concentrations than for IFN-y (Table I) . In three experiments with each type, 50 U/ml IFN-a or IFN-,Q had about the same potentiating activity as 5 U/ml IFN-y. Human rIL2 also Anti-IFN-7 Antibody Blocks the ADCC-stimulating Effect of LK Macrophages were pretreated with lymphokines ± neutralizing antibodies for 2 d and then tested for ADCC as in Table I . The anti-rIFN blocked the ADCC-stimulating activity of LK . The antihuman IL-2 (50 n.u .) does not neutralize mouse IL-2; it blocked the ADCC-stimulating activity of rhIL-2 but not that of the murine LK . The cultures containing the combination of LK, IL-2, and anti-IFN--y show that the antibody did not nonspecifically block increased ADCC since a strong augmentation was seen due to the IL-2 . * Viable targets (X 104/ml) at 9 h. $ Percent ADCC induced by pretreatment.
stimulated ADCC in the range of 5-50 U/ml (Table I) . When nonadherent cells from the peritoneal exudate population were similarly incubated with IL-2, they did not have any ADCC activity (not shown) .
Effect of IL-4 and IL-4-depleted Lymphokine . Treatment of macrophages with rIL4 did not stimulate ADCC, whereas Con A-induced lymphokine depleted of IL-4 retained its activity (Table II) . The results were seen, respectively, in three and four separate experiments. This suggests that IL-4 does not play a major role in this macrophage tumoricidal mechanism.
Anti-IFN-y Blocks Most of the Activity in Lymphokines. A neutralizing mAb was used to assess the contribution of IFN-y to the activity in lymphokine . ADCC-stimulating activity of the Con A-induced lymphokine and of 5 or 50 U/ml IFN-y . It did not block the activity of IL-2 . One concern with adding a neutralizing antibody into a reaction with macrophages is that nonspecific effects due to Fc binding may occur. The ability of IL-2 to boost ADCC in the presence of Con A-induced lymphokine and neutralizing anti-IFN-y antibody suggests that the antibody specifically abrogates the effect of IFN-y in the lymphokine . Anti-human IL-2 blocked the activity of human rIL-2. These results suggest that IFN-y is the major factor in Con A-induced lymphokine which promotes macrophage ADCC, although IL-2 must also be considered since its concentration in lymphokine may be high enough to have some effect . Effect of Antiserum Concentration and E/T Ratio on Stimulated ADCC . The previous experiments used a single E/T ratio and a relatively high antibody concentration. The enhancement of killing by IFN-y is evident at 1 :2,000 dilution of antiserum, which gives considerable spontaneous ADCC . Enhancement is also seen at 10-fold and marginally at 100-fold lower amounts of antiserum for which there is no spontaneous activity ; results typical of three experiments are shown in Table IV . An E/T ratio of 5:1 allows enhanced cytotoxicity of 70 to >90% of targets, but enhancement by IFN-y is seen even at a ratio of 1 :1 (Table IV) .
Discussion
Our assay for ADCC, visual counts of surviving targets, is possible due to the extreme sensitivity of the R 1 targets to this type of macrophage killing. The results read at 24 h are very similar to the 9-h point, although the targets in the nonmacrophage and no antibody controls frequently double in this time span. This suggests that most of the killing occurs in the first 9 h and that the subsequent growth of the survivors is similar to that of control tumor cells. We defined "cytotoxicity" in terms of fewer targets compared to controls ; tumorilysis is only demonstrated when the number of surviving targets is less than the initial number . This was the case with the higher concentrations of the active lymphokines studied .
IFN-y is well known as a stimulator of macrophage nonspecific tumoricidal activity (2) . The results presented here demonstrate that IFN-y is also the major factor in mitogen-induced lymphokine which stimulates macrophage ADCC, although IL-2, IFN-a, and IFN-0 have this activity as well. The effect is dose dependent and is seen with a range of antibody concentrations . The IL-2-stimulated ADCC appears to be a direct effect of the lymphokine on macrophages since nonadherent peritoneal cells did not manifest this activity . The possibility that IL-2 acted indirectly via the few percent of lymphoid cells in the macrophage fraction was not investigated . Malkovsky et al. (6) reported that IL-2 also stimulates human monocyte nonspecific tumoricidal activity . IL-4 mediates multiple biological activities that affect various cell lineages . With respect to macrophages, IL-4 has been shown to coregulate their CSFdependent growth, to increase la expression, and to augment their ability to present antigen (reviewed in references 7 and 8). Crawford et al. (8) recently showed that IL-4 stimulates peritoneal macrophages for increased nonspecific cytotoxicity, but we found no effect of this LK in our ADCC system (Table II) . Crawford et al . (8) also showed that IL-4 increases the Fc receptor expression (attributed to FcR type II) of bone marrow-derived macrophages. ADCC reactions may differ in effector mechanisms and method of triggering, reviewed by Johnson et al. (9) . Therefore, our study of ADCC in one population of peritoneal macrophages, that elicited by proteose peptone, should be expanded to other types of cells and assays .
Other cytokines that interact with macrophages include IL-1, TNF, and CSF. Macrophage-CSF induces nonspecific tumoricidal activity in murine macrophages and enhances that activity induced by crude sources of lymphokine factors (10) and by IFN--y (Ralph, P., and I . Nakoinz, manuscript in preparation) . M-CSF alone does not modulate macrophage ADCC, but it enhances the effect of mitogen-induced lymphokine, and the IFNs and IL-2 (Ralph, P ., and 1. Nakoinz, manuscript in preparation) . M-CSF is not detectable in mouse spleen lymphokine (10) . A preliminary investigation of IL-1 (Genzyme, Boston, MA) and human rTNF (Cetus Corp.) showed no effect on ADCC at 1, 5, or 50 U/ml in our assay (unpublished observations).
We showed previously that LPS could stimulate ADCC similarly to lymphokines, but only at high concentrations of 1 jAg/ml (1). The activity of mitogeninduced lymphokine and individual factors studied here is not due to LPS because of their low content measured by the Limulus assay, because polymyxin B does not abrogate the effect, and because LPS-hyporesponsive C3H/HeJ mice respond to protein factors (Ralph, P., and 1. Nakoinz, manuscript in preparation) .
This study used a polyclonal antiserum. All four murine IgG classes are capable of directing macrophage ADCC to tumor targets (3, 9) , although the most active mAbs tend to be of the IgG2a isotype (9) . Immune lymphokine is reported to increase macrophage expression of Fc receptors for IgG2a but not IgG2b (11) . The macrophage capacity for cytolysis must also be considered in the stimulation of ADCC. In this respect, the difference between ADCC and "nonspecific" killing of tumor targets is remarkable . With ADCC, maximum activity increases through day 2 of culture with LK while nonspecific killing is close to zero at this time (1, 10). In addition, the ADCC-sensitive R1 target is resistant to lymphokineinduced, nonspecific killing. Further study is required to determine the contributions of Fc receptors and "cytolytic capacity" of lymphokine-activated macrophages in ADCC .
